Risk factors for the recurrence of hepatocellular carcinoma after radiofrequency ablation of hepatocellular carcinoma in patients with hepatitis C

Table 2 Comparison of patients with and without recurrence of primary HCC in the liver.

Variable	With recurrence(n = 12)	Without recurrence(n = 14)	P
Age (yr)	67.8 ± 5.7	67.9 ± 7.8	NS
Gender
Male	6	11	NS
Female	6	3
Nodule diameter (mm)	23.5 ± 7.2	32.0 ± 24.2	NS
Number of primary
HCC nodules
Uninodular	3	10	<0.05
Multinodular	9	4
Child-Pugh A	6	9	NS
B	6	5
Platelet (/mL)	8.2 ± 3.6	13.3 ± 6.9	<0.05
Albumin (g/L)	3.2 ± 0.3	3.4 ± 0.4	NS
AST (IU/L)	197.7 ± 416.0	87.2 ± 47.2	NS
Post-RFA AST (IU/L)	72.4 ± 25.4	70.8 ± 2.96	NS
ALT (IU/L)	98.0± 121.6	76 ± 43.5	NS
Post-RFA ALT (IU/L)	49.3 ±21.4	55.4 ± 30.5	NS
Post-RFA treatment
UDCA	10	12	NS
SNMC	5	4
IFN	0	2